Biblio
Export 1991 results:
Author Title Type [ Year
Filters: First Letter Of Last Name is B [Clear All Filters]
“Ketogenic Medium Chain Triglycerides Increase Brain Energy Metabolism in Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 2, pp. 551-561, 2018.
, “Lentivirus-Mediated HDAC3 Inhibition Attenuates Oxidative Stress in APPswe/PS1dE9 Mice.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1411-1424, 2018.
, “Lifetime Risk Factors for Functional and Cognitive Outcomes in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1283-1299, 2018.
, “A Long Journey into Aging, Brain Aging, and Alzheimer's Disease Following the Oxidative Stress Tracks.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1319-1335, 2018.
, “A Long Journey into Aging, Brain Aging, and Alzheimer's Disease Following the Oxidative Stress Tracks.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1319-1335, 2018.
, “A Long Journey into Aging, Brain Aging, and Alzheimer's Disease Following the Oxidative Stress Tracks.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1319-1335, 2018.
, “Longitudinal Changes in Serum Glucose Levels are Associated with Metabolic Changes in Alzheimer's Disease Related Brain Regions.”, J Alzheimers Dis, vol. 62, no. 2, pp. 833-840, 2018.
, “Longitudinal Changes in Serum Glucose Levels are Associated with Metabolic Changes in Alzheimer's Disease Related Brain Regions.”, J Alzheimers Dis, vol. 62, no. 2, pp. 833-840, 2018.
, “Longitudinal Modeling of Functional Decline Associated with Pathologic Alzheimer's Disease in Older Persons without Cognitive Impairment.”, J Alzheimers Dis, vol. 62, no. 2, pp. 855-865, 2018.
, “Longitudinal Modeling of Functional Decline Associated with Pathologic Alzheimer's Disease in Older Persons without Cognitive Impairment.”, J Alzheimers Dis, vol. 62, no. 2, pp. 855-865, 2018.
, “Longitudinal Neuroimaging Analysis in Mild-Moderate Alzheimer's Disease Patients Treated with Plasma Exchange with 5% Human Albumin.”, J Alzheimers Dis, vol. 61, no. 1, pp. 321-332, 2018.
, “Longitudinal Neuroimaging Analysis in Mild-Moderate Alzheimer's Disease Patients Treated with Plasma Exchange with 5% Human Albumin.”, J Alzheimers Dis, vol. 61, no. 1, pp. 321-332, 2018.
, “Longitudinal Neuroimaging Analysis in Mild-Moderate Alzheimer's Disease Patients Treated with Plasma Exchange with 5% Human Albumin.”, J Alzheimers Dis, vol. 61, no. 1, pp. 321-332, 2018.
, “Long-Term Follow Up of Patients with Mild-to-Moderate Alzheimer's Disease Treated with Bapineuzumab in a Phase III, Open-Label, Extension Study.”, J Alzheimers Dis, vol. 64, no. 3, pp. 689-707, 2018.
, “Long-Term Follow Up of Patients with Mild-to-Moderate Alzheimer's Disease Treated with Bapineuzumab in a Phase III, Open-Label, Extension Study.”, J Alzheimers Dis, vol. 64, no. 3, pp. 689-707, 2018.
, “Low Cerebrospinal Fluid Aβ42 and Aβ40 are Related to White Matter Lesions in Cognitively Normal Elderly.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1877-1886, 2018.
, “Low Cerebrospinal Fluid Aβ42 and Aβ40 are Related to White Matter Lesions in Cognitively Normal Elderly.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1877-1886, 2018.
, “Lower Serum Antibodies Against Tau Protein and Heavy Neurofilament in Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 3, pp. 751-760, 2018.
, “Mechanism of Tau Hyperphosphorylation Involving Lysosomal Enzyme Asparagine Endopeptidase in a Mouse Model of Brain Ischemia.”, J Alzheimers Dis, vol. 63, no. 2, pp. 821-833, 2018.
, “Memantine for the Treatment of Dementia: A Review on its Current and Future Applications.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1223-1240, 2018.
, “Memantine for the Treatment of Dementia: A Review on its Current and Future Applications.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1223-1240, 2018.
, “Memory Binding Test Predicts Incident Dementia: Results from the Einstein Aging Study.”, J Alzheimers Dis, vol. 62, no. 1, pp. 293-304, 2018.
, “Meta-Analysis of Personality Traits in Alzheimer's Disease: A Comparison with Healthy Subjects.”, J Alzheimers Dis, vol. 62, no. 2, pp. 773-787, 2018.
, “Metabolic Syndrome and Amyloid Accumulation in the Aging Brain.”, J Alzheimers Dis, vol. 65, no. 2, pp. 629-639, 2018.
, “Metabolic Syndrome and Amyloid Accumulation in the Aging Brain.”, J Alzheimers Dis, vol. 65, no. 2, pp. 629-639, 2018.
,